Skip to main content
. 2022 Nov 15;17(11):e0277706. doi: 10.1371/journal.pone.0277706

Fig 2. Change in AST/ALT ratio and BMI from baseline.

Fig 2

Value at baseline for A: Mean AST/ALT of 1.21 for placebo and 1.22 for aleglitazar, B: Mean BMI of 29.5 kg/m2 for placebo and 29.3 kg/m2 for aleglitazar. Error bars indicate 95% CIs. Change from baseline is significantly different in the aleglitazar and the placebo group at all timepoints ≥1 month for both AST/ALT ratio and BMI (all P<0.001).